Literature DB >> 23956249

Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.

Sofia Ramiro1, Carmen Stolwijk2, Astrid van Tubergen2, Désirée van der Heijde3, Maxime Dougados4, Filip van den Bosch5, Robert Landewé6.   

Abstract

OBJECTIVES: To describe the evolution of radiographic abnormalities of the spine in patients with ankylosing spondylitis (AS).
METHODS: Patients with AS were followed prospectively with 2 yearly radiographs for 12 years. The modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) was scored by two readers (R1 and R2). New syndesmophytes at uninvolved vertebral corners were computed. Radiographic progression was investigated using generalised estimating equations.
RESULTS: 809 radiographs (presenting 520 at 2 yearly intervals) from 186 patients (70% men, mean age 43 (SD 12) years, mean 20 (SD 12) years since symptom onset and 83% HLA-B27 positive) were included. Mean mSASSS at baseline was 11.6 (16.2). While the course of progression in individual patients was highly variable, and still occurred in patients with decades of symptom duration, mean 2 year progression was 2.0 (3.5) mSASSS units. Over the entire follow-up, at least one new syndesmophyte was found in 55% (R1) and 63% (R2) of patients (38% (R1) and 39% (R2) of all intervals). In 24% of patients (39% of intervals), there was no progression. A progression ≥5 mSASSS units occurred in 22% of patients (or in 12% of intervals). At the group level, a linear time course model fitted the data best, with a constant rate over the entire 12 year interval of 0.98 mSASSS units/year. Radiographic progression occurred significantly faster in men, in HLA-B27 positive patients and in patients with a baseline mSASSS≥10.
CONCLUSIONS: Long term radiographic progression in AS is highly variable in the individual patient, more severe in HLA-B27 positive men and still occurs after decades of disease. At the group level, however, progression in AS follows an approximately linear course. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  ankylosing spondylitis; mSASSS; outcome measures; radiographic damage; spondyloarthritis; syndesmophytes

Mesh:

Substances:

Year:  2013        PMID: 23956249     DOI: 10.1136/annrheumdis-2013-204055

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  65 in total

1.  Dynamics of syndesmophyte growth in AS as measured by quantitative CT: heterogeneity within and among vertebral disc spaces.

Authors:  Sovira Tan; Jianhua Yao; John A Flynn; Lawrence Yao; Michael M Ward
Journal:  Rheumatology (Oxford)       Date:  2014-11-12       Impact factor: 7.580

Review 2.  Ankylosis in ankylosing spondylitis: current concepts.

Authors:  Nigil Haroon
Journal:  Clin Rheumatol       Date:  2015-06       Impact factor: 2.980

Review 3.  Radiographic Progression in Ankylosing Spondylitis: From Prognostication to Disease Modification.

Authors:  Ismail Sari; Nigil Haroon
Journal:  Curr Rheumatol Rep       Date:  2018-11-08       Impact factor: 4.592

Review 4.  Syndesmophyte growth in ankylosing spondylitis.

Authors:  Sovira Tan; Runsheng Wang; Michael M Ward
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

5.  Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis.

Authors:  Gianluca Sambataro; Domenico Sambataro; Riccardo Polosa
Journal:  Ther Adv Chronic Dis       Date:  2017-05-10       Impact factor: 5.091

6.  Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease.

Authors:  Latika Gupta; Shruti Bhattacharya; Vikas Agarwal; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2016-10-13       Impact factor: 2.980

Review 7.  Mechanism of New Bone Formation in Axial Spondyloarthritis.

Authors:  Denis Poddubnyy; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2017-09       Impact factor: 4.592

Review 8.  Treat to Target in Axial Spondyloarthritis: Pros, Cons, and Future Directions.

Authors:  Jean W Liew; Maureen Dubreuil
Journal:  Rheum Dis Clin North Am       Date:  2020-05       Impact factor: 2.670

9.  Comparison of MRI-defined back muscles volume between patients with ankylosing spondylitis and control patients with chronic back pain: age and spinopelvic alignment matched study.

Authors:  Doo Hee Bok; Jihye Kim; Tae-Hwan Kim
Journal:  Eur Spine J       Date:  2016-11-24       Impact factor: 3.134

10.  Gender differences in factors associated with low quality of life and depression in Korean patients with ankylosing spondylitis.

Authors:  Bora Nam; Bon San Koo; Seoung Wan Nam; Ji-Hui Shin; Yoonah Song; Soo-Kyung Cho; Yoon-Kyoung Sung; Tae-Hwan Kim
Journal:  Qual Life Res       Date:  2021-03-10       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.